To investigate whether CD44 promoted BCC proliferation in a bone microenvironment, we knocked down the expression of CD44 in MDA-MB-231BO cells through shRNA lentivirus (Fig. 5a). The gene discussed is CD44; the disease is skin basal cell carcinoma.